Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > talk to the CEO

<< Previous

Bullboard Posts

Next >>

Comment by WarrantOfficeron Jan 04, 2023 4:22pm

138 Views

Post# 35203601

RE:talk to the CEO

I participated in the Zoom meeting. Only lasted about 12 minutes. My question was equity financing. They are seeking 50 million, which will incude financing to get the Iodine line moving. Brent could not obviously state specifics, he did mention they are in current negotions with a couple of financial instituions and we should hear news in a couple of months.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”